Member Exclusive News

Blood stem cell editing could provide the answer for sickle cell anemia

Using the CRISPR-Cas9 system, researchers have successfully shown that the clinical symptoms of sickle cell anemia and beta-thalassemia can be reversed by targeting CD90 stem cells.

Aug 01, 2019

Please sign in or register for FREE

No comments yet.